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Abstract
Background: Interleukin-8 (IL-8) is known for its roles in inflammation and plays critical roles in the development
of pain. Its expression increases in the brain after peripheral inflammation. Prefrontal cortex, including the anterior
cingulate cortex (ACC), is a forebrain structure known for its roles in pain transmission and modulation. Painful
stimuli potentiate the prefrontal synaptic transmission, however, little is known about the expression of IL-8 and its
role in the enhanced ACC synaptic transmission in animals with persistent inflammatory pain.
Findings: In the present study, we examined IL-8 expression in the ACC, somatosensory cortex (SSC), and the
dorsal horn of lumbar spinal cord following hind-paw administration of complete Freund’s adjuvant (CFA) in mice
and its effects on the ACC synaptic transmission. Quantification of IL-8 at protein level (by ELISA) revealed
enhanced expression in the ACC and spinal cord during the chronic phases of CFA-induced peripheral
inflammation. In vitro whole-cell patch-clamp recordings revealed that IL-8 significantly enhanced synaptic
transmission through increased probability of neurotransmitter release in the ACC slice. ACC local infusion of
repertaxin, a non-competitive allosteric blocker of IL-8 receptors, notably prolonged the paw withdrawal latency to
thermal radian heat stimuli bilaterally in mice.
Conclusions: Our findings suggest that up-regulation of IL-8 in the ACC partly attributable to the enhanced
prefrontal synaptic transmission in the mice with persistent inflammatory pain.
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Findings
Chemokines, a family of proinflammatory cytokines play
a role in immune system regulation, cell growth, cell
development, and inflammation [1]. Interleukin-8 (IL-8),
a l s ok n o w na sC X C L 8 ,i sa na chemokine and its main
function is chemotaxis of neutrophils and T lymphocytes
[2]. In the immune system, IL-8 exerts its biological
action by binding to seven-transmembrane G-protein-
coupled receptors named CXCR1 and CXCR2. In the
CNS, CXCR2 receptors have been described on astro-
cytes, microglia, and neurons [3]. The chemokine IL-8 is
known to be synthesized by microglial cells and astro-
cytes [4]. IL-8 may be an important factor in intercellular
communication between glia and neurons by rapidly
altering the excitability of neurons, probably through pre-
synaptic mechanisms [5]. Repertaxin is a new non-com-
petitive allosteric blocker of IL-8 receptors (CXCR1/R2),
which by locking CXCR1/R2 in an inactive conformation
prevents receptor signaling and human polymorphonuc-
lear leukocyte (PMN) chemotaxis [6].
Studies using different experimental approaches consis-
tently suggest that the anterior cingulate cortex (ACC)
plays important roles in processing pain-related informa-
tion in humans and in the behavioral responses to nox-
ious stimuli or tissue injury in animals [7]. Our previous
studies show that synaptict r a n s m i s s i o ni nt h eA C Ci s
enhanced in mice with persistent inflammatory pain
induced by hind-paw injection of complete Freund’s
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cytokines in the CNS are likely to behave as neuromodu-
lators. Recent studies have demonstrated that IL-8 and
other chemokines elicit rapid signaling events in neurons
to modulate excitatory and inhibitory synaptic activities
[11]. It has been implicated in chronic inflammatory pain
states [12]. Evidence shows that IL-8 expression increases
in the spinal dorsal horn in a rat model of lumbar disc
herniation [13]. The pathophysiological condition, such
as traumatic brain injuries, induces local brain and sys-
temic stress response, in which IL-8 is considered as a
key mediator of neuroinflammation [14]. Our previous
studies show that synaptict r a n s m i s s i o ni nt h eA C Ci s
enhanced in mice with persistent inflammatory pain
induced by hind-paw injection of CFA, and presynaptic
alterations caused by peripheral inflammation is partly
attributable to the up-regulation of tumor necrosis factor
alpha (TNF-a) in the ACC [8,9]. The synergistic effect on
IL-8 secretion of TNF-a has been implicated [15]. How-
ever, it is not clear what is the role of IL-8 in the
enhanced ACC synaptic transmission in animals with
persistent inflammatory pain. To address this question,
we performed experiments to quantify the IL-8 expres-
sion and identify its roles in ACC synaptic transmission
and pain modulation after hind-paw inflammation in
vitro and in vivo.
To test whether the IL-8 was involved in enhanced
synaptic transmission in the ACC after chronic pain, we
measured IL-8 concentration in ACC at 1, 3, 5, and 7
days after hind-paw injection of CFA. Increased expres-
sion of IL-8 in the ACC was seen at day 1 following
peripheral administration of CFA (the acute phase of
inflammation) and remained elevated during the chronic
phases (day3-day7) of inflammation (Figure 1A). To rule
out the possibility that increased expression of IL-8 is a
nonspecific result of chronic pain, not limited to
changes in cingulate cortex, we tested IL-8 in the soma-
tosensory cortex (SSC) of the same animals. As shown
in Figure 1B, expression of IL-8 in the SSC was
increased at day 1 following peripheral administration of
CFA and decreased to the basal level during the chronic
phases (day 3-day7) (Figure 1B). Last, we also tested
IL-8 in the dorsal horn of lumbar spinal cord in the
same animals. Expression of IL-8 was increased follow-
ing peripheral administration of CFA (day 1-day7)
(Figure 1C). These results suggest that increased expres-
sion of IL-8 is regionally specific to the ACC and dorsal
horn of lumbar spinal cord during the chronic phases of
hind-paw inflammation.
The present result shows that the increment time
course of IL-8 amount in the ACC is consistent with the
time window of enhanced synaptic transmission with
persistent inflammatory pain, raising the possibility of IL-
8 playing a role in the modulation of ACC synaptic trans-
mission. To test this hypothesis, excitatory postsynaptic
currents (EPSCs) from layer II-III neurons were elicited
by a bipolar tungsten-stimulating electrode placed in
layer V of the ACC. The input-output relationships, mea-
suring EPSCs amplitude (output) as a function of the
afferent stimulus intensity (input), were compared as
described [8]. Synaptic transmission in the ACC was sig-
nificantly enhanced in the slices of mice after hind-paw
CFA injection within day 3 to day 7 (Figure 2A and 2B).
ACC local infusion of repertaxin (0.5 μg/0.5 μl), a non-
competitive allosteric blocker of IL-8 receptors, notably
reversed the enhanced synaptic transmissions in the mice
with hind-paw CFA injection (Figure 2A). Furthermore,
bath application IL-8 (50 ng/ml, 4 h) significantly
increased the synaptic transmission in the slices from the
control mice (Figure 2B). This result is consistent with
the idea that persistent inflammation leads to an increase
of endogenous IL-8 that shares one or more steps with
exogenous IL-8.
Next, to test whether presynaptic mechanisms contri-
butes to altered synaptic transmission by IL-8, we mea-
sured paired-pulse facilitation (PPF, the ratio of EPSC2/
EPSC1) in neurons from the ACC. PPF was recorded
with intervals of 35, 50, 75, 100, and 150 ms. PPF has
Figure 1 Levels of IL-8 in the brain following hind-paw CFA injection. (A) There was a significant increase in the IL-8 concentration in the
ACC at d1, d3, d5, and d7 after CFA injection compared with saline injection (n = 6 in each time point). (B) There was a significant increase in
the IL-8 concentration in the SSC at d1 but no difference at d3, d5, and d7 after CFA injection compared with saline injection (n = 6 in each
time point). (C) There was a significant increase in the IL-8 concentration in the dorsal horn of lumbar spinal cord at d1, d3, d5, and d7 after
CFA injection compared with saline injection (n = 6 in each time point). ** P < 0.01 compared with saline controls.
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of transmitter release [16]. PPF was significantly
decreased in ACC slices from the mice with hind-paw
CFA injection and ACC local infusion of repertaxin
abolished the alteration of PPF (Figure 2C). In addition,
incubation of exogenous IL-8 (50 ng/ml) for 4 h also
reduced the PPF in the slices from control mice (Figure
2D), indicating an increased presynaptic probability of
transmitter release by IL-8.
To further determine the presynaptic or postsynaptic
component associated with an increase of the synaptic
transmission, we recorded AMPA receptor mediated
miniature excitatory postsynaptic currents (mEPSCs) in
the ACC slices (Figure 3A). A significant increase in
mEPSC frequency and amplitude was detected in CFA-
injected mice as compared to saline controls (Figure 3B
and 3C). ACC local infusion of repertaxin abolished the
alteration of mEPSC frequency and amplitude (Figure 3B
and 3C). These results indicate that up-regulation of
excitatory synaptic transmission by IL-8 is likely due to
both presynaptic transmitter release and postsynaptic
AMPA receptor modifications in the ACC synapses.
To further evaluate the role of IL-8 in the pain proce-
dure, we detected the thermal hyperalgesia in the mice
with ACC local infusion of repertaxin. The paw withdra-
wal latency (PWL) to thermal radian heat stimuli is a
widely used nociceptive measure to study hyperalgesic
behavior. As illustrated in Figure 4, CFA-treated ipsilat-
eral paws (left) showed a significant decrease in PWL
when compared to the control mice (Figure 4A). Interest-
ingly, PWL in contralateral paws (right) also showed a
significant decrease when compared to right paws of con-
trol mice (Figure 4B). Microinjection of repertaxin
(0.5 μg/0.5 μl) into the ACC induced a significant
increase in PWL in CFA-treated ipsilateral and contralat-
eral hind-paws (Figure 4A and 4B).
NR2B containing NMDA receptors in the ACC play a
critical role in the pain procedure [17]. Western blot
Figure 2 Potentiation of synaptic transmission in the ACC slices
by IL-8. (A) Representative recordings of evoked EPSCs in the ACC
slices from saline, CFA-injected, and ACC infusion of repertaxin mice
(upper). Plot of input-output curves showed the enhancement of
synaptic transmission in the ACC of CFA-injected mice and ACC
infusion of repertaxin partially inhibited CFA-induced synaptic
transmission. n = 9 slices/4 mice in each group, * P <0 . 0 5 ,* *P <0 . 0 1
compared with saline-injected mice;
# P < 0.05 compared with CFA-
injected mice. (B) Representative recordings of evoked EPSCs in the
control and IL-8 incubated ACC slices (upper). Plot of input-output
curves showed enhancement of synaptic transmission by IL-8
perfusion; however, ACC infusion of repertaxin partially inhibited IL-8-
induced synaptic transmission. n = 8 slices/4 mice in each group, * P <
0.05, ** P < 0.01 compared with control;
# P < 0.05 compared with IL-8
incubated slices. (C) Representative traces of PPF with an interval of 50
ms recorded in the saline, CFA-injected, and ACC infusion of repertaxin
mice (upper). PPF was notably reduced in CFA-injected mice, and ACC
infusion of repertaxin reversed the reduced PPF in the ACC of CFA-
injected mice. n = 10 slices/4 mice in each group, * P < 0.05, ** P <
0.01 compared with saline-injected mice. (D) Representative
recordings of PPF in the control and IL-8 incubated ACC slices (upper).
PPF was significantly reduced by IL-8 incubated slices, and ACC
infusion of repertaxin reversed the reduced PPF in the ACC of IL-8
incubated slices. n = 9 slices/4 mice in each group, *P <0 . 0 5 ,* *P <
0.01 compared with control.
Figure 3 Effects of repertaxin on basal glutamatergic synaptic
transmission. (A) mEPSCs recorded a holding potential of -70 mV
in pyramidal neurons from saline, CFA-injected, and ACC infusion of
repertaxin mice. (B) Cumulative frequency (left) and amplitude
(right) histogram of the mEPSCs in neurons from saline, CFA-
injected, and ACC infusion of repertaxin mice. (C) Summery of
mEPSCs frequency (left) and amplitude (right) in neurons from
saline (n = 10 neurons/4 mice), CFA-injected (n = 11 neurons/4
mice), and repertaxin (n = 12 neurons/4 mice) infusion mice. ** p <
0.01 compared with saline-injected mice;
# p < 0.05 compared to
the CFA-injected mice.
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NR2B expressions in the ACC were notably increased at
3 d after CFA-injection (Figure 4C, E-F). However, no
significant alteration was detected in the NR2A expres-
sion in the ACC after injury (Figure 4D). Microinjection
of repertaxin (0.5 μg/0.5 μl) into the ACC induced a sig-
nificant decrease in NR2B or phosphorylated NR2B
expression in CFA-injected mice (Figure 4C-F). These
findings imply that changes in NR2B containing
NMDARs are highly related to the expression of IL-8 in
the ACC.
In the present study, we found that IL-8 expression
was increased specifically in the ACC and might be
involved in the enhanced synaptic transmission after
persistent inflammatory pain. CFA-induced peripheral
inflammation induces robust glial activation and proin-
flammatory cytokines release including IL-8 at CNS,
supporting a role of enhanced IL-8 expression at CNS
in eliciting behavioral hypersensitivity [18]. In present
study, IL-8 expression was found increase in the ACC at
least lasting for one week after CFA hind-paw injection.
This time course is parallel to the time window of
enhanced synaptic transmission in the ACC induced by
CFA injection as the previous study shown [8]. As a
result, the increase of IL-8 expression in the ACC would
affect normal signaling events. Since the prefrontal cor-
tex is thought to be involved in the processes of chronic
pain modulation [7,19], the increased ACC IL-8 expres-
sion strongly suggests that IL-8 is linked in some way to
the processes of inflammatory pain. IL-8 is known to be
synthesized by microglial cells and astrocytes [4]. Glial
cells, including astrocytes and microglia, have recently
been implicated in neuropathic pain [20]. These glial
cells form close interactions with neurons and thus may
modulate nociceptive transmission under pathological
conditions. Even though microglia seems insensitive to
neuronal activities, such as high-frequency stimulation
or synaptic plasticity observed in the hippocampus [21],
it is possible that microglia is response to the inflamma-
tory stimuli in the pain related brain region such as the
ACC. Inhibition of the thermal hyperalgesia by ACC
local infusion of IL-8 receptor blocker provides the
direct evidences of this possibility. Our previous studies
show that TNF-a is partly attributable to the enhanced
synaptic transmission in the ACC in mice with hind-
paw injection of CFA [9]. TNF-a shows the synergistic
effect on IL-8 secretion [15]. It is reasonable that IL-8
involves in the modulation of synaptic transmission in
the ACC after CFA injection. However, we can not
exclude the possibility that other cytokines may also
involve in the synaptic transmission.
In the present study we found that IL-8 was increased
both in spinal cord and ACC after inflammatory pain.
However, in the somatosensory cortex expression of
IL-8 in the SSC was increased only in the acute phase
(one day following peripheral administration of CFA). It
is consistent that ACC and spinal cord are the key brain
regions involved in the pain central sensitization
[22-24]. As shown in many other studies the inflamed
ipsilateral paws show a significant decrease in PWL than
control paws [25,26]. Also, the contralateral paws of
CFA-injected group show a slight decrease in PWL than
control paws, even though the decrease in PWL of con-
tralateral paws is much smaller than that on the ipsilat-
eral side [27,28]. This indicates that in chronic
inflammatory pain condition the decrease in PWL to
thermal stimuli is not confined only to the CFA-
Figure 4 Changes of thermal hyperalgesia and NR2B expression
by IL-8. (A) Compared with left paws of control, CFA-treated ipsilateral
paws (left) showed a significant decrease in PWL; however,
microinjection of repertaxin (0.5 μg/0.5 μl) into the ACC induced a
significant increase in PWL in CFA-treated ipsilateral hind-paws. (B)
Compared to right paws of control, CFA-treated contralateral paws
(right) also showed a notably decrease in PWL, and microinjection of
repertaxin (0.5 μg/0.5 μl) into the ACC induced a significant increase in
PWL in CFA-treated contralateral hind-paws. n = 6 in each group.
** p < 0.01 compared with saline control;
# p < 0.05 compared with
CFA-injected alone. (C) Western blot analysis was performed using
antibodies for NR2A, NR2B, and phosphorylated NR2B at Ser-1303
(p-Ser1303-NR2B). (D) There was no difference in NR2A expression
among three groups. (E-F) NR2B and phosphorylated NR2B
expressions in the ACC were notably increased at 3 d after CFA-
injection; however, microinjection of repertaxin (0.5 μg/0.5 μl) into the
ACC induced a significant decrease in NR2B or phosphorylated NR2B
expression in CFA-injected mice. n = 6 in each group. * p < 0.05, ** p <
0.01 compared with control;
# p < 0.05 compared with CFA-injected
alone.
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tralateral paws. Consistent with this report, we find that
unilateral CFA injection causes a bilateral decrease in
PWL in present study. ACC infusion of IL-8 receptor
blocker repertaxin leads to prolong PWL bilaterally, sug-
gesting IL-8 in the ACC modulates the thermal hyperal-
gesia to peripheral inflammatory injury.
Present results provide the evidences that IL-8 may
modulate glutamatergic synaptic transmission through
both presynaptic and postsynaptic mechanism. This is
demonstrated by decreased paired-pulse facilitation in
ACC slice recordings and reduced APMA receptor-
mediated EPSCs amplitude. The ACC NMDA receptor
activities have a strong association with chronic pain
[17]. The similarity in the IL-8 expression time course
and roles of NMDA receptors in the pain process raises
a possible relationship between IL-8 expression in the
prefrontal cortex and NMDA receptor activity. Present
results provide support for a novel role for IL-8 in the
control of NR2B containing NMDA receptors.
Taken together, these results suggest that the up-regu-
lation of IL-8 is involved in the enhanced alteration of
synaptic transmission in the prefrontal cortex, and that
IL-8 may play a role in the development of persistent
inflammatory pain.
Materials and methods
Experiments were carried out on C57BL/6 mice (8-10
weeks old of age). All animal protocols used were
approved by the Animal Care and Use Committee of the
Fourth Military Medical University. Mice were housed
under a 12 h light/dark cycle with food and water pro-
vided ad libitum. To induce inflammatory pain, 10 μlo f
50% CFA (Sigma, St. Louis, MO) was injected subcuta-
neously into the dorsal surface of one hind-paw. To mea-
surement of IL-8 in the ACC, SSC, and the dorsal horn of
lumbar spinal cord, mice were killed at various days after
CFA injection by decapitation and the tissues were rapidly
removed at 4°C and frozen on ice. The tissues were
weighted and homogenized in ice-cold PBS using a Potter
homogenizer. The homogenates were centrifuged for
10 min (5000 rpm, 4°C). 100 μl of supernatant were taken
in duplicate to measure IL-8. The amounts of IL-8 in the
ACC, SSC, and spinal cord prepared at various days after
injection of CFA were determined using anti-mouse IL-8
E L I S AK i t s( R & DS y s t e m s ,M i n n e a p o l i s ,M N ,U S A )
according to the manufacturer’s protocol. The concentra-
tion of the IL-8 was quantified as picogram antigen per
milligram of protein.
For recording the synaptic transmission in the ACC
slices, mice were anesthetized with halothane, and coro-
nal brain slices (300 μm in thickness) were obtained
using a vibrating slicer as previously described [8]. After
recovery for least 1 h, slices were placed in the record-
ing chamber and superfused at 2-3 ml/min with oxyge-
nated (95% O2 and 5% CO2) artificial cerebrospinal fluid
(aCSF) containing (in mM) 124 NaCl, 2.5 KCl, 2 CaCl2,
1M g S O 4,2 5N a H C O 3,1N a H 2PO4,1 0g l u c o s e .T h e
slices were covered with a nylon mesh to prevent move-
ment of the tissue. Experiments were performed in a
recording chamber on the stage of an Olympus Micro-
scope (Olympus, Japan) with infrared digital interference
contrast optics for visualization of whole-cell patch
clamp recording. EPSCs were recorded from layer II
pyramidal neurons holding at -70 mV with an Axon
200B amplifier (Molecular Devices, Palo Alto, CA) and
digitized at a sampling rate of 10 kHz. The pyramidal
neurons were identified by the firing properties accord-
ing to the previous study [29]. The stimulations were
delivered by a bipolar tungsten stimulating electrode
placed in layer V of the ACC at 0.05 Hz. Patch pipettes
(3-5 MΩ) were filled with an internal solution contain-
ing (in mM) 145 K-gluconate, 5 NaCl, 1 MgCl2,0 . 2
EGTA, 10 HEPES, 2 Mg-ATP and 0.1 Na3-GTP, which
had an osmolarity of 280 mOsm and pH of 7.2. Experi-
ments were performed at room temperature. Only
experiments where there was less than 20% change in
access resistance were included in analysis.
For the ACC infusion, mice were anesthetized under
ketamine and xylazine. 24-guage guide cannulas were
implanted bilaterally into the ACC (0.7 mm anterior to
Bregma, ± 0.4 mm lateral from the midline, 1.7 mm
beneath the surface of the skull). Mice were given at least
1 week to recover after cannula implantation. The
30-gauge injection cannula was 0.1 mm lower than the
guide. For intra-ACC infusion, 0.5 μl repertaxin (4 μg/μl)
or saline was delivered bilaterally within 90 s using a
pump. Four hours later, thermal hyperalgesia was mea-
sured. The method of Hargreaves et al. (1988) was used to
assess paw withdrawal latency (PWL) to a thermal noci-
ceptive stimulus [26]. To assess thermal nociceptive
responses, a plantar analgesia instrument (BME410A,
Institute of Biological Medicine, Academy of Medical
Science, China) was used. Animals were placed in indivi-
dual plastic boxes and allowed to adjust to the environ-
ment for 1 h. Thermal hyperalgesia was assessed by
measuring the latency of paw withdrawal in response to a
radiant heat source. Mice were housed individually into
Plexiglas chambers on an elevated glass platform, under
which a radiant heat source was applied to the plantar sur-
face of the hind-paw through the glass plate. The heat
source was turned off when the mouse lifted the foot,
allowing the measurement of time from onset of radiant
heat application to withdrawal of the mouse hind-paw.
This time was defined as the PWL. Both paws were tested
alternately at 5 min intervals for a total of five trials. A
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paws were tested independently with 10 min interval
between trials.
Western blot analysis was performed as described pre-
viously [30]. Equal amount of proteins (50 μg) from the
ACC were separated and electrotransferred onto PDVF
membranes (Invitrogen), which were probed with antibo-
dies for, NR2A (dilution ratio 1:200, Millipore, Billerica,
MA), NR2B (dilution ratio 1:500), and phosphorylation of
NR2B at Ser1303 (dilution ratio 1:1000, Millipore), and
with b-actin (dilution ratio 1:5000, Millipore) as loading
control. For data quantitation, band intensity was
expressed relative to the loading control (b-actin). The
membranes were incubated with horseradish peroxidase
conjugated secondary antibodies (anti-rabbit/anti-mouse
IgG for the primary antibodies), and bands were visualized
using an ECL system (Perkin Elmer).
Results were expressed as mean ± SEM. Statistical
comparisons were performed using one-way analysis of
variance (ANOVA) using the Student-Newmann-Keuls
for post-hoc comparisons. In all cases, P <0 . 0 5w a s
considered statistically significant.
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